Medpace Holdings, Inc. MEDP

Updated: 11 Sep 2026

NASDAQ | Biotech | Clinical contract research services

No signal published yet

We already track Medpace Holdings and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Medpace Holdings free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Clinical contract research services
We're already tracking Medpace Holdings, Inc. — here are the latest events we've registered

Recent News

  • On July 22, 2026, Medpace reported its second-quarter 2026 financial results, with revenue increasing 17.2% year-over-year to $707.3 million and net income rising to $121.4 million. Net new business awards grew 28.2% to $795.7 million, bringing total backlog to $3.01 billion. The company also raised its full-year 2026 revenue guidance to a range of $2.805 billion to $2.885 billion.

What Firelda Watch includes for Medpace Holdings, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Medpace Holdings, Inc. will be delivered in the same format.

Want to follow Medpace Holdings, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Medpace Holdings free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Medpace Holdings, Inc. MEDP
Medpace Holdings — follow and we'll monitor it
Follow Medpace Holdings free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.